ImmuneSpec

ImmuneSpec is a biotech service company offering advanced immunopeptidomics: identification of maximized numbers of MHC I and MHC II associated peptides like neoantigens, tumor associated antigens (for development of immunotherapeutics & PM) but also pathogen derived antigens (for development of prophylactic vaccines). In the context of immunogenicity risk assessment we can decipher potential T cell epitopes from biotherapeutics for selecting safe, high efficacy biotherapeutics.